Charles Nichols
Professor of Pharmacology at Louisiana State University Health Sciences Center in New Orleans
Key Impact
He is a leading psychedelic pharmacologist whose work has clarified 5-HT2A receptor biology, psychedelic-induced gene expression and plasticity, and anti-inflammatory mechanisms relevant to psychiatric and neurological therapeutics.
Background & Research
Charles D. Nichols is a pharmacologist at LSU Health Sciences Center in New Orleans who has studied the cellular, molecular, genetic, and behavioral effects of psychedelics for more than 25 years. His work spans classic psychedelics, 5-MeO-DMT, LSD, and related compounds, with key contributions to understanding receptor pharmacology, brain signaling changes, and potential therapeutic mechanisms. He is also a founding member and current president of the International Society for Research on Psychedelics.
Collaboration Network
17 collaborators· click a node to visit their profile
Full network →